Empagliflozin reduces kidney fibrosis and improves kidney function by alternative macrophage activation in rats with 5/6-nephrectomy.
Lu YP, Wu HW, Zhu T, Li XT, Zuo J, Hasan AA, Reichetzeder C, Delic D, Yard B, Klein T, Krämer BK, Zhang ZY, Wang XH, Yin LH, Dai Y, Zheng ZH, Hocher B.
Lu YP, et al. Among authors: zuo j.
Biomed Pharmacother. 2022 Dec;156:113947. doi: 10.1016/j.biopha.2022.113947. Epub 2022 Oct 31.
Biomed Pharmacother. 2022.
PMID: 36411661
Free article.